Enveric Biosciences, Inc. (ENVB) Tops Q3 EPS by 28c

Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q3 EPS of ($0.24), $0.28 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• SpaceX (SPCX) call put ratio 1.7 calls to 1 put as share price up 5%
• Dynatrace Is Said to Offer Zero Coupon on Exchangeable Bond